Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877)

Shanghai Junshi Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,712	3,788	6,031	3,507	3,385	1,221
Trading Asset Securities	600	-	-	-	0.02	0.02
Cash & Short-Term Investments	3,312	3,788	6,031	3,507	3,385	1,221
Cash Growth	-32.16%	-37.19%	71.98%	3.59%	177.26%	-55.91%
Accounts Receivable	449.9	483.23	238.19	1,301	664.44	163.21
Other Receivables	201.79	374.01	26.18	28.05	22.84	9.7
Receivables	651.69	857.23	264.36	1,329	687.28	172.91
Inventory	554.11	538.05	599.02	484.6	343.43	180.67
Other Current Assets	303.37	387.59	322.36	524.79	283	336.67
Total Current Assets	4,821	5,571	7,216	5,845	4,699	1,911
Property, Plant & Equipment	3,919	3,809	3,020	2,801	2,377	1,851
Long-Term Investments	1,149	1,133	1,403	1,485	422.9	141.59
Other Intangible Assets	533.02	546.96	316.09	264.98	162.09	142.92
Long-Term Deferred Tax Assets	102.23	103.4	228.43	88.55	26.11	20.59
Long-Term Deferred Charges	-	12.6	23.24	27.79	13.24	9.23
Other Long-Term Assets	464.71	167.14	351.17	522.34	297.73	335.47
Total Assets	10,989	11,343	12,558	11,035	7,997	4,412
Accounts Payable	1,030	125.19	67.07	63.17	55.69	40.36
Accrued Expenses	228.16	1,046	1,032	1,603	826.28	302.05
Short-Term Debt	667.17	452.44	351.36	-	21.23	76.89
Current Portion of Long-Term Debt	154.43	86.96	40.39	10.6	231.11	-
Current Portion of Leases	-	35.93	43.66	34.47	25.22	13.85
Current Income Taxes Payable	-	17.98	-	63.08	-	-
Current Unearned Revenue	154.28	146.3	4.11	45.8	43.14	-
Other Current Liabilities	52.2	527.92	227.3	181.59	269.79	145.08
Total Current Liabilities	2,286	2,438	1,766	2,001	1,472	578.23
Long-Term Debt	1,738	1,196	839.58	490	542.22	744.9
Long-Term Leases	9.52	17.45	46.58	93.13	30.99	27.33
Long-Term Unearned Revenue	177.2	183.46	122.06	122.46	122.65	56.32
Other Long-Term Liabilities	173.22	187.15	7.5	11.5	1.28	27.15
Total Liabilities	4,384	4,022	2,782	2,719	2,170	1,434
Common Stock	985.69	985.69	982.87	910.76	872.5	784.15
Additional Paid-In Capital	-	15,395	15,346	11,423	8,632	4,180
Retained Earnings	-9,705	-9,060	-6,777	-4,389	-3,668	-1,999
Treasury Stock	-30.89	-26.89	-	-	-	-
Comprensive Income & Other	15,228	-142.07	-68.41	0.21	-9.39	12.54
Total Common Equity	6,478	7,151	9,484	7,945	5,828	2,978
Minority Interest	126.63	169.39	292.83	371.28	-0	-0
Shareholders' Equity	6,605	7,321	9,776	8,316	5,828	2,978
Total Liabilities & Equity	10,989	11,343	12,558	11,035	7,997	4,412
Total Debt	2,569	1,789	1,322	628.19	850.78	862.97
Net Cash (Debt)	742.29	2,000	4,709	2,878	2,534	357.9
Net Cash Growth	-78.64%	-57.54%	63.60%	13.58%	608.08%	-83.72%
Net Cash Per Share	0.75	2.03	5.13	3.23	3.08	0.46
Filing Date Shares Outstanding	984.87	985.01	982.87	910.76	872.5	784.15
Total Common Shares Outstanding	984.87	985.01	982.87	910.76	872.5	784.15
Working Capital	2,535	3,133	5,450	3,843	3,226	1,333
Book Value Per Share	6.58	7.26	9.65	8.72	6.68	3.80
Tangible Book Value	5,945	6,604	9,168	7,680	5,666	2,835
Tangible Book Value Per Share	6.04	6.70	9.33	8.43	6.49	3.62
Buildings	-	1,419	1,032	891.83	880.3	79.03
Machinery	-	1,921	1,514	1,419	1,247	348.52
Construction In Progress	-	1,325	1,044	801.93	415.55	1,480

Source: S&P Capital IQ. Standard template. Financial Sources.